Application(s)
|
Antiviral agent
|
Application(s)
|
prophylactic drug for influenza
|
Application(s)
|
Also has antiparkinsonian props.
|
Mechanism of Action
|
Dopaminergic
|
Mechanism of Action
|
Postulated antiparkinsonian mechanism: causes dopamine release from dopaminergic terminals that may remain in the substantia-nigra of parkinsonian patients
|
Mechanism of Action
|
May cause dopamine release from central sites other than the substantia-nigra
|
Mechanism of Action
|
Exact virucidal mechanism not completely understood
|
Mechanism of Action
|
Apparent virucidal mechanism: influenza type-A specific; influenza type-A viral nucleic-acid into host-cell
|
Mechanism of Action
|
May interfere with viral penetration into cells.
|